About: Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
source	Medline; PMC
abstract	covid:3a5364e4465fe5bf7e506fee801213556638dd1a#abstract
has issue date	2020-05-12(xsd:dateTime)
bibo:doi	10.7326/m20-1550
bibo:pmid	32422065
has license	no-cc
sha1sum (hex)	3a5364e4465fe5bf7e506fee801213556638dd1a
schema:url	https://doi.org/10.7326/m20-1550
resource representing a document's title	Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)
has PubMed Central identifier	PMC7236891
has PubMed identifier	32422065
schema:publication	Ann Intern Med
resource representing a document's body	covid:3a5364e4465fe5bf7e506fee801213556638dd1a#body_text
is schema:about of	named entity '2019' named entity 'Coronavirus' named entity 'Patients' named entity 'Lopinavir and Ritonavir' named entity 'COVID' named entity 'ritonavir' named entity 'pharmacokinetic' named entity 'COVID-19' named entity 'COVID-19' named entity 'antiinflammatory' named entity 'HIV' named entity 'plasma proteins' named entity 'half-maximal' named entity 'drug metabolism' named entity 'cytochrome' named entity '7.1' named entity 'IL-6' named entity 'HIV-1' named entity 'tumor necrosis factor' named entity 'pharmacokinetic' named entity 'COVID-19' named entity 'ritonavir' named entity 'enzyme' named entity 'C-reactive protein' named entity 'ritonavir' named entity 'clinical trials' named entity 'IL-6' named entity 'lopinavir' named entity 'EC50' named entity 'EC50' named entity 'ritonavir' named entity 'trough levels' named entity 'SARS-CoV-2' named entity 'HIV' named entity 'adverse effects' named entity 'trough levels' named entity 'COVID-19' named entity 'C-reactive protein' named entity 'downregulation' named entity 'drug metabolism' named entity 'proinflammatory cytokines' named entity 'inflammation' named entity 'High levels' named entity 'correlation' named entity 'protein binding' named entity 'small sample' named entity 'HIV' named entity 'cytochrome P450 enzyme' named entity 'C-reactive protein' named entity 'trough levels' named entity 'lopinavir' named entity 'lopinavir' named entity 'Spearman correlation' named entity 'lopinavir' named entity 'COVID-19' named entity 'IL-6' named entity 'IL-6' named entity 'effective dose' named entity '1, 2' named entity 'lopinavir' named entity 'SARS-CoV-2' named entity 'Lopinavir' named entity 'lopinavir' named entity 'ritonavir' named entity 'lopinavir' named entity 'lopinavir' named entity 'interleukin' named entity 'lopinavir' named entity 'lopinavir' named entity 'Coronavirus Disease 2019' named entity 'Pharmacokinetics' named entity 'Disease' named entity 'Lopinavir' named entity 'COVID-19' named entity 'With' named entity 'Ritonavir' named entity 'LOPINAVIR AND RITONAVIR' named entity 'PATIENTS' named entity 'CORONAVIRUS DISEASE 2019' named entity 'BRIEF' named entity 'PHARMACOKINETICS' named entity 'RESEARCH REPORT'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software